China's Generic Drug Market, 2012-2016
Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016
By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market. There are more and more drug varieties and the quality becomes better and better. Chinas generic drugs can meet the treatment needs of most common diseases and the market share has accounted for more than 85%, at the same time, the health care costs become a large expense in China, the expensive new drugs are facing the growth resistance.
As for the competitive landscape of generic drug sales in different regions, in the advantaged areas such as Beijing, Shanghai, Guangzhou and some other first-tier cities, the foreign investment enterprises and joint ventures occupy an absolute advantage; the annual sales amount of a multinational enterprise in Shanghai Ruijin Hospital reached more than CNY 100 million, this number equivalent to the annual sales level of a medium-sized domestic pharmaceutical enterprise.
In the second-tier cities such as Nanjing, Wuhan and Hangzhou, the domestic brand enterprises formed a strong competitive position, such as Yangtze River Pharmaceutical Group, Harbin Pharmaceutical Group Holding Co., Ltd, Sanjiu Medical & Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd and so on.
In the market of third-tier or four-tier market, especially the rural area markets of counties, villages and towns are flooded with numerous small brands and there is no leading brand in these markets. This means that there are huge opportunities in these markets. If the per capita consumption of drugs in rural market is CNY 120 / year, the rural population in China is nearly 900 million; the market capacity will be CNY 108 billion / year, which means that there are huge opportunities in rural market for generic drugs.
Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016
By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market. There are more and more drug varieties and the quality becomes better and better. Chinas generic drugs can meet the treatment needs of most common diseases and the market share has accounted for more than 85%, at the same time, the health care costs become a large expense in China, the expensive new drugs are facing the growth resistance.
As for the competitive landscape of generic drug sales in different regions, in the advantaged areas such as Beijing, Shanghai, Guangzhou and some other first-tier cities, the foreign investment enterprises and joint ventures occupy an absolute advantage; the annual sales amount of a multinational enterprise in Shanghai Ruijin Hospital reached more than CNY 100 million, this number equivalent to the annual sales level of a medium-sized domestic pharmaceutical enterprise.
In the second-tier cities such as Nanjing, Wuhan and Hangzhou, the domestic brand enterprises formed a strong competitive position, such as Yangtze River Pharmaceutical Group, Harbin Pharmaceutical Group Holding Co., Ltd, Sanjiu Medical & Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd and so on.
In the market of third-tier or four-tier market, especially the rural area markets of counties, villages and towns are flooded with numerous small brands and there is no leading brand in these markets. This means that there are huge opportunities in these markets. If the per capita consumption of drugs in rural market is CNY 120 / year, the rural population in China is nearly 900 million; the market capacity will be CNY 108 billion / year, which means that there are huge opportunities in rural market for generic drugs.
No comments:
Post a Comment